Jason Wang

Practice Areas

Finance & Insurance; Cybersecurity & Data; Bankruptcy & Reorganization

Career

2024.02-: SGLA Law Firm; Lawyer

2020.07-2024.01: East China Normal University Law School; Lecturer

Professional Memberships

2023.11-:China Insurance Society；Expert

2020.03-:Center of Insurance Law, Shanghai Jiao Tong University；Research fellow

2020.03-:Institute of Insurance Law, Zhongnan University of Economics and Law； research fellow

2021.09-:Insurance Law Research Committee of China Law Society；‌‌Council Member

Publications

1.The Effectiveness of Pre-existing Condition Clauses under the Duty of Disclosure Rules in Insurance Law‍, Insurance Research, 2024(2).

2.‍The Legal Basis and Rule Construction of Renewal Rights in Commercial Health Insurance”‍, Private Law, 2022(1).

‍3.Research on Third‑Party Premium Payment in Insurance Contracts from the Perspective of the Civil Code”‍, Insurance Research, 2021(12).

4.The Nature and Rule Application of Waiting‑Period Clauses in Commercial Health Insurance‍, Journal of Civil and Commercial Law, 2021(1).

Clients

China Export & Credit Insurance Corporation

Haitong Unitrust International Financial Leasing Co., Ltd.‌

Zhonghai Trust Co.,Ltd

Fostar Insurance Agency Co., Ltd.

Gezhouba Scinor (Rizhao) Environmental Technology Co., Ltd

Shanghai Mingpin Medical Data Technology Co., Ltd

Industry Sector Expertise

Insurance law；Bankruptcy law

Languages Spoken

Mandarin;English

Work Highlights

2025: A digital technology company:“Overseas Loan under Domestic Guarantee

Project”, involving USD 20 million.

2024: A property insurance company:“Litigation Property Preservation Liability Insurance Project”.

2024: A medical-data company:“Personal-Information Protection Compliance Project”.

2023: A limited company:“Bankruptcy Project”, involving CNY 500  million.

2023: A export credit insurance corporation: “Credit Insurance Case”, involving USD 140 million.

2022: A trust company:“Channel Business Dispute Case”, with a subject amount of involving CNY 200 million.

2021: A Medical Third-Party Administrators: “Third-Party Cooperation Project”.

2021: A limited company:“Liquidation Project”, involving CNY 160  million.